SCHEMBL21709032

SCHEMBL21709032

c1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5)cc4)nc(-c4cccc(-c5nc(-c6ccccc6)nc6ccccc56)c4)n3)cc2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.69
▸ KMT2A Q03164 3/20 0.69
▸ ATM Q13315 1/20 0.69
▸ WHR1 P49842 1/20 0.51
▸ ADORA2A P29274 4/20 0.48
▸ NUDT1 P36639 1/20 0.46
▸ CYP1A2 P05177 4/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ CYP2C9 P11712 3/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ CLK4 Q9HAZ1 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ MAPK1 P28482 1/20 0.46
▸ NR1I3 Q14994 3/20 0.46
▸ VDR P11473 1/20 0.46
▸ CYP2B6 P20813 1/20 0.46
▸ AHR P35869 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22483157 0.98 MEN1 (0.67) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL23606772 0.97 MEN1 (0.68) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL22355391 0.95 MEN1 (0.71) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL22483467 0.95 MEN1 (0.71) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL24403760 0.95 MEN1 (0.71) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL17720984 0.95 MEN1 (0.71) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL18504101 0.95 MEN1 (0.66) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL18504128 0.95 MEN1 (0.61) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL18504116 0.93 MEN1 (0.64) MEN1KMT2AATMWHR1ADORA2A
SCHEMBL24084040 0.93 MEN1 (0.58) MEN1KMT2AATMWHR1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220199911-A1 AN ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-06-23 — — US disclosed
WO-2020032424-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING, AS HOST MATERIAL, MIXTURE OF DIFFERENT KINDS OF COMPOUNDS, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2020-02-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220199911-A1 AN ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF ESR1, EML4, OCIAD1 MEN1 777/4885KMT2A 1740/4885ATM 2546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback